Suppr超能文献

地塞米松-昂丹司琼静脉混合液的相容性和物理性质

Compatibility and Physical Properties of Dexamethasone-Ondansetron Intravenous Admixture.

作者信息

Suknuntha Krit, Wattanapoka Kotchakorn, Poonpattanachai Pilor, Titipornwanich Natanan, Sripakdee Warunsuda

机构信息

Prince of Songkla University, Hatyai, Songkhla, Thailand.

Songklanagarind Hospital, Songkhla, Thailand.

出版信息

Hosp Pharm. 2022 Oct;57(5):666-672. doi: 10.1177/00185787221074563. Epub 2022 Mar 2.

Abstract

This work aimed at evaluating the impact of different concentrations and final volumes on the compatibility and physical properties of dexamethasone-ondansetron intravenous (IV) admixture. The IV admixture of dexamethasone-ondansetron was prepared at different concentrations using normal saline solution as solvent. The final volume of the IV admixture was prepared at 50 and 100 ml. Turbidity was measured as an indicator of physical compatibility of the IV admixture of dexamethasone-ondansetron using UV-visible spectrophotometer and the pH of the IV admixture was measured on day 0, 7,14, and, 21 as an index of chemical stability. Also, the particle size and potential molecular interactions of the admixtures were determined using particle size analyzer and Fourier Transform infrared spectrometry analysis, respectively. Additionally, the effect of preservatives on the IV admixture was also evaluated. Precipitation was observed for mixtures with amounts of dexamethasone and ondansetron exceeding 8 and 16 mg, respectively, in a final volume of 50 ml. For all mixtures with final volume of 100 ml, clear solutions void of any precipitates were observed. The pH of the solution had no effect on the precipitation of the dexamethasone-ondansetron during storage up to 21 days. Analyses of the precipitate formed revealed the presence of molecular interactions between dexamethasone and ondansetron. The benzyl alcohol used as a preservative affected the compatibility of the IV admixture compatibility. Thus, for the preparation of clear, physically compatible normal saline solutions of dexamethasone-ondansetron IV admixture, the maximum amounts of the respective drugs should not exceed 8 and 16 mg in total volume of 50 ml or 20 and 16 mg in a final volume of 100 ml.

摘要

本研究旨在评估不同浓度和终体积对地塞米松-昂丹司琼静脉注射混合液的配伍性和物理性质的影响。以生理盐水为溶剂,制备不同浓度的地塞米松-昂丹司琼静脉注射混合液。静脉注射混合液的终体积分别制备为50和100ml。使用紫外可见分光光度计测量浊度,作为地塞米松-昂丹司琼静脉注射混合液物理配伍性的指标,并在第0、7、14和21天测量静脉注射混合液的pH值,作为化学稳定性指标。此外,分别使用粒度分析仪和傅里叶变换红外光谱分析法测定混合液的粒径和潜在分子相互作用。另外,还评估了防腐剂对静脉注射混合液的影响。在50ml终体积中,分别含有超过8mg地塞米松和16mg昂丹司琼的混合物出现沉淀。对于所有终体积为100ml的混合物,观察到无任何沉淀的澄清溶液。在长达21天的储存期间,溶液的pH值对地塞米松-昂丹司琼的沉淀没有影响。对形成的沉淀进行分析发现,地塞米松和昂丹司琼之间存在分子相互作用。用作防腐剂的苯甲醇影响静脉注射混合液的配伍性。因此,为制备澄清、物理配伍的地塞米松-昂丹司琼静脉注射生理盐水溶液,在50ml总体积中各药物的最大量不应超过8mg和16mg,或在100ml终体积中不超过20mg和16mg。

相似文献

本文引用的文献

4
NCCN Guidelines Insights: Antiemesis, Version 2.2017.NCCN 指南解读:止吐药,2017 年第 2 版。
J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.
7
Chemotherapy-induced nausea and vomiting.化疗引起的恶心和呕吐。
N Engl J Med. 2008 Jun 5;358(23):2482-94. doi: 10.1056/NEJMra0706547.
9

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验